Convalescent Plasma for Outpatients with Covid-19

被引：2
|
作者：
Fisher, David [1 ]
Malnick, Stephen [1 ]
机构：
[1] Kaplan Med Ctr, Rehovot, Israel
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年
关键词：
THERAPY;
D O I：
10.1056/NEJMc2114591
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
To the Editor: In the Covid-19 Convalescent Plasma in Outpatients (C3PO) trial,(1) Korley et al., members of the Strategies to Innovate Emergency Care Clinical Trials Network (SIREN), administered convalescent plasma to high-risk outpatients within 1 week after the onset of symptoms of Covid-19. It is unclear why the authors selected 1 week instead of a shorter time frame, since it has been shown that the 30-day and 60-day mortality benefits of convalescent plasma have been observed when it is administered within 3 days after diagnosis and that the benefit dissipates after this point.(2,3) The aim of their trial was to . . .
引用
收藏
页数：1
相关论文
共 50 条
  • [21] COVID-19 convalescent plasma: phase 2
    Knudson, C. Michael
    Jackson, J. Brooks
    TRANSFUSION, 2020, 60 (06) : 1332 - 1333
  • [22] Convalescent plasma therapy in patients with COVID-19
    Altuntas, Fevzi
    Ata, Naim
    Yigenoglu, Tugce Nur
    Basci, Semih
    Dal, Mehmet Sinan
    Korkmaz, Serdal
    Namdaroglu, Sinem
    Basturk, Abdulkadir
    Hacibekiroglu, Tuba
    Dogu, Mehmet Hilmi
    Berber, Ilhami
    Dal, Kursat
    Kinik, Kerem
    Haznedaroglu, Ibrahim
    Yilmaz, Fatma Meric
    Kilic, Isa
    Demircioglu, Sinan
    Yosunkaya, Alper
    Erkurt, Mehmet Ali
    Turgut, Burhan
    Caglayan, Murat
    Celik, Osman
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (01) : 102955
  • [23] Use of convalescent plasma in the treatment of COVID-19
    Michael J. Joyner
    Nigel Paneth
    Arturo Casadevall
    Nature Reviews Nephrology, 2023, 19 : 271 - 271
  • [24] Convalescent Plasma for the Treatment of Severe COVID-19
    Franchini, Massimo
    Liumbruno, Giancarlo Maria
    BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 31 - 38
  • [25] Covid-19 patients treated with convalescent plasma
    Nissen-Meyer, Lise Sofie Haug
    Macpherson, Magnhild Eide
    Skeie, Linda Gail
    Hvalryg, Marte
    Llohn, Abid Hussain
    Steinsvag, Tine Torsvik
    Fenstad, Mona Hoysaeter
    Tveita, Anders
    Kristoffersen, Einar K.
    Sundic, Tatjana
    Lund-Johansen, Fridtjof
    Vaage, John Torgils
    Flesland, Oystein
    Dyrhol-Riise, Anne Ma
    Holter, Jan Cato
    Hervig, Tor Audun
    Fevang, Borre
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2023, 143 (11) : 958 - 962
  • [26] Donating convalescent plasma for COVID-19 patients
    Black, Emily
    BRITISH DENTAL JOURNAL, 2020, 229 (10) : 643 - 643
  • [27] COVID-19, Hypercoagulability, and Cautiousness with Convalescent Plasma
    Sanfilippo, Filippo
    La Rosa, Valeria
    Oliveri, Francesco
    Astuto, Marinella
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (02) : 257 - 258
  • [28] Convalescent plasma for COVID-19: Back to the future
    Roberts, David J.
    Miflin, Gail
    Estcourt, Lise
    TRANSFUSION MEDICINE, 2020, 30 (03) : 174 - 176
  • [29] Convalescent plasma for COVID-19: Promising, not proven
    Mucha, Simon R.
    Quraishy, NurJehan
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2020, 87 (11) : 664 - 670
  • [30] Late Treatment for COVID-19 With Convalescent Plasma
    Senefeld, Jonathon W.
    Paneth, Nigel S.
    Carter, Rickey E.
    Wright, R. Scott
    Fairweather, DeLisa
    Bruno, Katelyn A.
    Joyner, Michael J.
    CHEST, 2022, 162 (05) : E283 - E284
12345